Home・Elenco Azioni・ANI Pharmaceuticals Inc

ANI Pharmaceuticals Inc

Aperta

SettoreSettore sanitario

79.09 -0.63

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

77.72

Massimo

80.16

Metriche Chiave
By Trading Economics
Entrata	-61K 27M
Vendite	-9.6M 237M
P/E Media del settore	20.044 64.641
EPS	1.68
Margine di Profitto	11.551
Dipendenti	970
EBITDA	-20M 57M

Raccomandazioni
By TipRanks
Raccomandazioni	Acquista
Previsioni per 12 mesi	+36.15% upside

Dividendi
By Acuity
Utili prossimi	7 ago 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	-91M 1.8B
Apertura precedente	79.72
Chiusura precedente	79.09

Notizie sul Sentiment di mercato

By Acuity

14%

86%

19 / 340 Classifica in Healthcare

ANI Pharmaceuticals Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

3 ago 2026, 19:46 UTC

ANI Pharmaceuticals is trading higher since Friday's close, despite a flat overall session. The stock remains near the lower end of its one-month range.

31 lug 2026, 20:06 UTC

ANI Pharmaceuticals Inc. shares are declining amid unusual volatility, with trading lower since Thursday as inflation concerns rise alongside US Treasury yields and crude oil prices.

30 lug 2026, 20:09 UTC

ANI Pharmaceuticals Inc. shares are lower during Thursday's session, following a notable dip in late morning trading amid mixed economic signals impacting broader market conditions.

29 lug 2026, 19:19 UTC

ANI Pharmaceuticals shares are higher, rebounding after an earlier pullback. Market sentiment is influenced by expectations for the Federal Reserve's monetary policy announcement today.

28 lug 2026, 20:02 UTC

ANI Pharmaceuticals is advancing today, continuing an upward trend since Monday, despite declines in broader market sectors, particularly technology stocks in Asia.

24 lug 2026, 20:06 UTC

News

ANI Pharmaceuticals shares are lower today amid mixed market sentiment for healthcare stocks. The company plans to discuss its Q2 2026 financial results on August 7, 2026.

22 lug 2026, 20:01 UTC

News

Shares of ANI Pharmaceuticals are lower amid concerns over potential tariffs on imported generic drugs. The stock is near the lower end of its one-month range.

21 lug 2026, 20:12 UTC

ANI Pharmaceuticals Inc. shares are lower in after-market trading, positioned below the 20-day moving average and near the lower end of their one-month range.

20 lug 2026, 19:46 UTC

News

Social Media

ANI Pharmaceuticals shares are lower despite positive results from the Phase 4 SYNCHRONICITY trial, which may support expanded use of ILUVIEN.

Confronto tra pari

Modifica del prezzo

ANI Pharmaceuticals Inc Previsione

Obiettivo di Prezzo

By TipRanks

36.15% in crescita

Previsioni per 12 mesi

Media 109 USD 36.15%

Alto 124 USD

Basso 91 USD

Basato su 6 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per ANI Pharmaceuticals Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

6 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 6 che hanno fornito valutazioni azionarie a ANI Pharmaceuticals Inc - Dist negli ultimi 3 mesi.

Sentiment

By Acuity

19 / 340 Classifica in Settore sanitario

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo ANI Pharmaceuticals Inc

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.